Cetuximab resistance mechanisms in head and neck cancer
Description
Overview of the most common mechanisms underlying therapeutic resistance against the anti-epidermal growth factor receptor (EGFR)-targeting antibody cetuximab in head and neck cancer
Acknowledgements
References
Ortiz-Cuaran, S., et al., Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers. Front Oncol, 2021. 11: p. 614332.
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
.gif)
